• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to secondary sidebar

Chronic Fatigue Syndrome

Chronic Fatigue Syndrome, Fibromyalgia, and IC Disease

  • Home
  • Fibromyalgia
    • Fibromyalgia Awareness
    • Fibromyalgia Research
    • Fibromyalgia Symptoms
    • Fibromyalgia Treatments
  • Chronic Fatigue
    • Awareness
    • Pediatric CFS
    • Research
    • Symptoms
    • Treatments
  • Chronic Illnesses
    • Cancer
    • Interstitial Cystitis
    • Irritable Bowel Syndrome
    • Chronic Pain
    • Vitamin D Deficiency
    • Women’s Health
  • Sandy’s Journey
  • Coping Corner
    • Disability
  • Articles
  • Resources
You are here: Home / Fibromyalgia / Fibromyalgia Treatments / New Drug Milnacipran Under Review for Fibromyalgia

New Drug Milnacipran Under Review for Fibromyalgia

4 Comments

755990_pills.jpg

The FDA has recently accepted review for a new drug, Milnacipran, that is to be used to treat Fibromyalgia.Forest Laboratories, Inc. and Cypress Bioscience, Inc. submitted their New Drug Application (NDA) for milnacipran for the treatment of Fibromyalgia based on results from a composite responder analysis requiring that each patient experienced concurrent and clinically meaningful improvements in three validated measures: pain, patient global impression of change in disease status, and physical function.

The FDA advised that they are moving toward class labeling for drugs used to treat Fibromyalgia, with any distinctions among therapies reflected in specific product labels instead of differences in the approved indications.

Milnacipran

Milnacipran is a unique dual-reuptake inhibitor that preferentially blocks the reuptake of norepinephrine with higher potency than serotonin, two neurotransmitters known to play an essential role in regulating pain and mood. It has been approved for a non-pain condition in over 50 countries, with real-world commercial experience outside the U.S. for 10 years. Milnacipran is jointly being developed for fibromyalgia in the United States market by Forest and its licensor, Cypress Bioscience, Inc. Milnacipran was originally developed by and is sold outside of the U.S. by Pierre Fabre Medicament. Fibromyalgia is defined by widespread chronic pain, as well as a broad spectrum of related symptoms including fatigue, cognitive dysfunction, and reduced physical function.

Source: redOrbit

Filed Under: Fibromyalgia Treatments Tagged With: Drugs/Supplements, Fibromyalgia, Milnacipran

Reader Interactions

Comments

  1. Gloria says

    March 6, 2008 at 12:57 pm

    Hi Sandy,
    I tried to email you to let you know I received the book, but the mail bounced back to me undeliverable. I hope everything is ok and that it was just your spam checker thinking it was spam ๐Ÿ™‚
    Thanks again ๐Ÿ™‚
    Gloria

    Reply
  2. Sandy Robinson says

    March 6, 2008 at 4:49 pm

    Thanks for letting me know you got it, Gloria! I’m not sure why the email didn’t go through. You are very welcome! ๐Ÿ™‚

    Reply
  3. Sara Stewart says

    March 10, 2008 at 3:46 pm

    Thank you for the heads-up!

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Recent Comments

  • Jeffery on How Can We Look So Good But Feel So Bad with CFS & Fibromyalgia?
  • Irakli Khvedelidze on How Can We Look So Good But Feel So Bad with CFS & Fibromyalgia?
  • Wayne Johnson on How Can We Look So Good But Feel So Bad with CFS & Fibromyalgia?
  • Chan KWAN on How Can We Look So Good But Feel So Bad with CFS & Fibromyalgia?
  • Ernesto Martinez on How Can We Look So Good But Feel So Bad with CFS & Fibromyalgia?
  • YUH on How Can We Look So Good But Feel So Bad with CFS & Fibromyalgia?
  • Analicia Burnett on How Can We Look So Good But Feel So Bad with CFS & Fibromyalgia?

Secondary Sidebar

Sub Topics

  • Fibromyalgia Awareness
  • Fibromyalgia Research
  • Fibromyalgia Symptoms
  • Fibromyalgia Treatments

Copyright © 2023 ยท FightingFatigue.org